Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
CDK8-Novel Therapeutic Opportunities
Ingeborg Menzl1, Agnieszka Witalisz-Siepracka2, Veronika Sexl3
1Institute of Pharmacology and Toxicology, University of Veterinary Medicine, 1210 Vienna, Austria. Ingeborg.menzl@vetmeduni.ac.at.
Abstract:
Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target for breast and prostate cancer, although no CDK8 inhibitors have entered the clinics. As the available inhibitors have been recently reviewed, we focus on the biological functions of CDK8 and provide an overview of the complexity of CDK8-dependent signaling throughout evolution and CDK8-dependent effects that may open novel treatment avenues.
Insights
Cyclin-dependent kinase 8 (CDK8) is a potential drug target for breast and prostate cancers. Understanding CDK8
Area of Science:
- Molecular biology
- Oncology
- Drug discovery
Background:
- Cancer therapy advancements rely on novel small-molecule inhibitors and predictive biomarkers.
- Cyclin-dependent kinase 8 (CDK8) is emerging as a potential therapeutic target for breast and prostate cancers.
- Currently, no CDK8 inhibitors are approved for clinical use.
Purpose of the Study:
- To review the biological functions of CDK8.
- To explore the evolutionary complexity of CDK8-dependent signaling pathways.
- To identify novel therapeutic strategies based on CDK8-dependent effects.
Main Methods:
- Literature review of CDK8 biological functions.
- Analysis of evolutionary signaling pathways involving CDK8.
- Exploration of potential therapeutic applications of CDK8 modulation.
Main Results:
- CDK8 plays a significant role in cellular signaling.
- CDK8-dependent pathways exhibit complex evolutionary patterns.
- Understanding these pathways may reveal new cancer treatment avenues.
Conclusions:
- CDK8 is a promising target for breast and prostate cancer therapies.
- Further research into CDK8's biological functions and signaling is warranted.
- Elucidating CDK8-dependent effects could lead to innovative treatment strategies.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Skeletal Muscle Relaxants: Therapeutic Uses

